NCT07736859

Brief Summary

To evaluate patient satisfaction following a HyFoSy examination performed as part of a fertility workup, by assessing the procedure's tolerability through a questionnaire administered immediately after the examination.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
12mo left

Started Sep 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 17, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 30, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2027

Last Updated

July 30, 2026

Status Verified

July 1, 2026

Enrollment Period

Same day

First QC Date

July 17, 2026

Last Update Submit

July 26, 2026

Conditions

Keywords

InfertilityHyFoSySatisfaction

Outcome Measures

Primary Outcomes (1)

  • Satisfaction level

    To evaluate patient satisfaction following a HyFoSy examination performed as part of an infertility workup by assessing the procedure's tolerability using a questionnaire administered immediately after the examination. Participants will be asked to rate their overall satisfaction on a scale from 0 to 10, with 10 indicating the highest level of satisfaction.

    30 minutes per participant (including time to provide study information and complete the questionnaire)

Secondary Outcomes (6)

  • Proportion of patients who received the information sheet and their satisfaction score with the information provided.

    30 minutes per participant (including time to provide study information and complete the questionnaire)

  • Distribution of pre-examination anxiety levels.

    30 minutes per participant (including time to provide study information and complete the questionnaire)

  • Proportion of painful experiences at each step of the procedure, and mean pain intensity during and after the examination (numerical rating scales).

    30 minutes per participant (including time to provide study information and complete the questionnaire)

  • Correlation between overall satisfaction score and patient characteristics and care pathways (sociodemographic data, gynecological and obstetric history, and medical and surgical history).

    30 minutes per participant (including time to provide study information and complete the questionnaire)

  • Correlation between overall satisfaction score and pain intensity.

    30 minutes per participant (including time to provide study information and complete the questionnaire)

  • +1 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women attending the fertility medicine unit who underwent a HyFoSy ultrasound examination.

You may qualify if:

  • Provided verbal informed consent after receiving full information about the study procedures
  • Women
  • Aged 18 years or older
  • Attending the fertility medicine unit and undergoing a HyFoSy ultrasound examination
  • Affiliated with, or covered by, a social security health insurance scheme

You may not qualify if:

  • Pregnant women
  • Women who are breastfeeding or in the postpartum period
  • Non-emancipated minors
  • Adults under legal protection (guardianship, curatorship, or judicial protection)
  • Adults unable to provide informed consent
  • Individuals deprived of liberty by judicial or administrative decision
  • Individuals receiving involuntary psychiatric care
  • Individuals who have declined participation in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHRU Nancy

Nancy, 54000, France

Location

MeSH Terms

Conditions

InfertilityPersonal Satisfaction

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital DiseasesBehavior

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PU-PH - ART Center coordinator

Study Record Dates

First Submitted

July 17, 2026

First Posted

July 30, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2027

Last Updated

July 30, 2026

Record last verified: 2026-07

Locations